Topic:Methocarbamol
Methocarbamol is a centrally acting muscle relaxant commonly used in horses to alleviate muscle spasms and discomfort associated with musculoskeletal conditions. It functions by depressing the central nervous system, leading to a reduction in muscle hyperactivity. Methocarbamol is often administered in cases of equine exertional rhabdomyolysis, commonly known as "tying-up," and other conditions that involve muscle tension or spasms. The pharmacokinetics, dosage, and administration routes of methocarbamol in horses are subjects of ongoing research to optimize therapeutic outcomes and minimize side effects. This page compiles peer-reviewed research studies and scholarly articles that explore the efficacy, safety, and pharmacological properties of methocarbamol in equine medicine.
Pharmacokinetics of methocarbamol and phenylbutazone in exercised Thoroughbred horses. Methocarbamol (MCBL) is commonly used in performance horses for the treatment of skeletal muscle disorders. Current regulatory recommendations for show horses and racehorses are based on a single oral dose of 5 g, although doses in excess of this are often administered. The goal of the current study was to characterize the disposition of MCBL following higher dose administration and administration in combination with another commonly used drug in performance horses, phenylbutazone (PBZ). Exercised Thoroughbred horses were administered various doses of MCBL as a sole agent and MCBL in combinat...
Methocarbamol suspension for the treatment of rhabdomyolysis in equines. Rhabdomyolysis in equines occurs in horses due to physical overexertion or underlying pathologic myopathy. Methocarbamol is a muscle relaxant that can be used in equines to treat symptoms associated with Rhabdomyolysis. Methocarbamol is available as a solution for injection but is not commercially available as an oral suspension. This article focuses on the treatment of Tying-up caused by overexertion, and details the treatment of Rhabdomyolysis with an oral suspension that was prepared for a veterinarian by a compounding pharmacist.
The pharmacology and pharmacokinetics of high-dose methocarbamol in horses. The haemodynamic, respiratory and behavioural effects and pharmacokinetics of methocarbamol were studied in eight healthy, adult horses after intravenous (i.v.) and oral administration of large dosages. Heart rate, cardiac output, mean pulmonary arterial blood pressure, systolic, diastolic and mean aortic blood pressure, respiratory rate and arterial blood gases did not change after either i.v. (30 mg/kg bodyweight [bwt]) or oral (50 and 100 mg/kg bwt) dosages of methocarbamol. Mild to moderate depression was observed in five of eight horses administered i.v. methocarbamol, and in all horses a...